Scenesse

Product manufactured by Clinuvel Inc.

Application Nr Approved Date Route Status External Links
NDA210797 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Scenesse® Is Indicated To Increase Pain Free Light Exposure In Adult Patients With A History Of Phototoxic Reactions From Erythropoietic Protoporphyria (epp). Scenesse Is A Melanocortin 1 Receptor (mc1-R) Agonist Indicated To Increase Pain Free Light Exposure In Adult Patients With A History Of Phototoxic Reactions From Erythropoietic Protoporphyria (epp)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Afamelanotide

Comments